查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1987476

动物用药品市场规模、份额、趋势和预测：按动物种类、产品类型和地区划分，2026-2034年

Animal Health Market Size, Share, Trends and Forecast by Animal Type, Product Type, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2025年全球动物保健市场规模为401亿美元，预计2034年将达到516亿美元，2026年至2034年的复合年增长率（CAGR）为2.73%。目前，北美市场主导地位，预计2025年将占44.9%的市场。推动该市场成长的主要因素是宠物饲养量的增加和对高品质兽医服务的需求。此外，人们对通用感染疾病的认识不断提高以及全球技术的进步也对动物保健市场份额产生影响。

通用感染疾病率的上升促使人们加大对疫苗、诊断和抗菌疗法的投资，以控制疾病传播。各国政府正在实施更严格的法规和监测计划，以监测和预防通用感染疾病的传播。同时，也开展了宣传宣传活动，倡导负责任的宠物饲养和疫苗接种，以降低社区疾病风险。畜牧业正在实施生物安全措施，以最大限度地减少感染疾病爆发，并确保符合食品安全标准。兽医诊断技术的进步使得早期发现和快速应对新出现的通用感染疾病成为可能。製药公司正在开发新的治疗方法和生物製药，以有效应对动物的通用感染疾病。兽医研发资金的增加正在推动通用感染疾病预防和治疗方案的创新。数位技术的整合正在加强疾病监测、疫情预测和即时数据共用。兽医和人类医疗保健部门之间的合作正在改善疾病控制的「相同健康」倡议。

美国动物用药品市场的需求成长主要源自于犬类皮肤病领域对标靶性和安全性治疗方法日益增长的需求。宠物饲养量的增加以及人们对皮肤病认知的提高，促使更多宠物因皮肤问题前往兽医诊所就诊。宠物饲主正在寻求专家治疗，以解决影响爱犬的过敏、感染疾病和自体免疫皮肤病。动物用药品的进步正推动靶向生物製药和更安全的局部治疗药物的研发。 2024年9月，礼来公司宣布其用于治疗犬类皮肤病的新型药物Zenrelia™（伊诺替尼片）获得美国食品药物管理局（FDA）核准并上市。该治疗方法为犬类皮肤病的治疗提供了一种有效且安全的选择，透过标靶治疗改善患病宠物的生命品质。兽医皮肤科医师正在采用精准医疗方法，根据具体病情制定个人化的治疗方案。低过敏性食品和营养补充剂的日益普及，也为犬类皮肤健康问题的全面管理提供了支持。诊断工具的创新使得皮肤疾病的快速识别成为可能，从而带来更有效的治疗性介入。兽医远端医疗的扩展提高了皮肤科会诊和远距治疗建议的可近性，进而促进了市场成长。

动物用药品市场趋势：

人们越来越关注医疗保健

根据动物健康产业统计数据，无论是伴侣动物或牲畜，预防性医疗保健实践都呈现显着趋势。宠物饲主和牲畜养殖户都意识到，早期发现并积极管理健康问题对于改善动物整体健康状况和降低疾病风险至关重要。 2022年5月，印度政府启动了“牲畜健康与疾病管制计画”，预算为525亿卢比，旨在控制严重的牲畜疾病并改善全国动物健康状况。此外，因疾病造成的畜牧业生产损失占10-15%，因此提高畜牧业的成本效益也成为重点。在各国，Z世代宠物饲主对医疗保健的意识也不断增强。例如，在印度，人们就诊兽医、及时接种疫苗以及为宠物提供均衡营养饮食的意愿显着提高。根据全球健康与安全指数发布的数据，墨西哥卫生署宣布了一项「国家健康促进日」计划，其中包括「疾病预防和控制规划指南：通用感染疾病」。这些建议体现了「同一健康」理念，并特别强调进行宣传活动以阻止和预防布氏桿菌症、狂犬病和绦虫病的传播。

生物技术和製药领域的进步

动物保健产业正经历生物技术和製药领域的快速发展，这正在改变动物疾病的诊断和治疗方式。先进的研究和突破性技术正在开发针对特定动物物种和健康状况的特效治疗方法、疫苗和精准药物。包括基因编辑、细胞疗法、聚合酵素链锁反应(PCR) 和 DNA定序在内的生物技术进步，为疑难杂症提供了极具前景的解决方案。此外，製药公司也加大研发投入，生产更有效率、更安全的动物用药。例如，澳洲生命科学公司 QBiotics Group Limited (QBiotics) 正在开发新型小分子抗癌剂和创伤治疗剂。该公司已获得澳洲农业和兽药管理局 (APVMA) 对其兽药 STELFONTA（Tigilanol Tigrete）的核准。此次核准标誌着澳洲首个用于治疗犬类非转移性中链甘油三酯 (MCT) 疾病（涵盖所有阶段）的药物问世。生物技术的发展使得磁振造影（MRI）和电脑断层扫描（CT）等先进影像技术得以发展，从而提供了关于动物（从宠物到牲畜）内部结构和异常情况的全面资讯。

宠物人性化和专业宠物护理的扩展。

人与宠物之间的关係正朝着宠物人性化的方向发展。宠物日益成为家庭的一份子，这导致宠物照护市场的消费者行为发生了显着变化。例如，在美国，35%的年轻人（24-35岁）已经拥有宠物或计划在不久的将来饲养宠物，其中19%的人在新冠疫情封锁期间将新宠物带回家。宠物饲主越来越愿意在优质专业的宠物护理产品和服务上投入更多资金，以确保他们心爱的宠物拥有健康快乐的生活。这一趋势推动了对高品质宠物营养产品、个人化护理、先进兽医服务以及各种专业用品的需求。例如，最近对宠物护理产品（如用于测量宠物敏捷性或与宠物一起运动的活动追踪项圈）的需求激增，尤其是在千禧世代和Y世代中。据领先的犬类活动追踪器製造商PitPat称，目前英国有10万隻狗佩戴了活动追踪器。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 二手资讯
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章：引言

第五章：全球动物用药品市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场区隔：依动物种类划分
  • 市场区隔：依产品类型
  • 市场区隔：按地区
  • 市场预测

第六章 市场区隔：依动物类型划分

  • 商业的
  • 宠物

第七章 市场区隔：依产品类型划分

  • 製药
  • 生物製药
  • 动物饲料用药添加剂
  • 诊断药物

第八章 市场区隔：依地区划分

  • 北美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 拉丁美洲

第九章：全球动物用药品产业：SWOT分析

第十章：全球动物用药品产业：价值链分析

第十一章 全球动物用药品产业：波特五力分析

第十二章：全球动物用药品产业：价格分析

  • 主要价格指标
  • 价格结构
  • 利润分析

第十三章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Bayer
    • Elanco
    • Merck
    • Merial
    • Zoetis Inc.
    • Biogenesis Bago
    • Boehringer Ingelheim
    • Ceva Sante Animale
    • Heska
    • Neogen
    • Novartis
    • Thermo Fisher Scientific
    • Vetoquinol
    • Virbac
Product Code: SR112026A1156

The global animal health market size was valued at USD 40.1 Billion in 2025. Looking forward, the market is projected to reach USD 51.6 Billion by 2034, exhibiting a CAGR of 2.73% during 2026-2034. North America currently dominates the market, holding a significant market share of 44.9% in 2025. The market is driven by the growing number of pet parents and their desire for high-quality veterinary care. Besides this, animal health market share is influenced by the rising awareness towards zoonotic diseases and various technological advancements across the globe.

Rising outbreaks of zoonotic infections are encouraging investments in vaccines, diagnostics, and antimicrobial therapies for disease control. Governments are implementing stricter regulations and surveillance programs to monitor and prevent zoonotic disease transmission. Public awareness campaigns are promoting responsible pet ownership and vaccination to reduce disease risks in communities. The livestock industry is adopting biosecurity measures to minimize outbreaks and ensure food safety standards compliance. Advances in veterinary diagnostics are enabling early detection and rapid response to emerging zoonotic threats. Pharmaceutical companies are developing novel therapeutics and biologics to combat zoonotic diseases effectively in animals. Increased funding for veterinary research is driving innovation in zoonotic disease prevention and treatment solutions. The integration of digital technologies is enhancing disease monitoring, outbreak prediction, and real-time data sharing. Collaborative efforts between veterinary and human healthcare sectors are improving one health initiatives for disease management.

The United States animal health market demand is driven by increasing requirements for targeted and safe treatments in canine dermatology. Rising pet adoption and greater awareness of skin disorders are fueling veterinary visits for dermatological conditions. Pet parents are seeking specialized treatments for allergies, infections, and autoimmune skin diseases affecting their dogs. Advances in veterinary pharmaceuticals are leading to the development of targeted biologics and safer topical therapies. In September 2024, Elanco announced the FDA approval and launch of Zenrelia(TM) (ilunocitinib tablets), a new treatment for canine dermatology. This solution provides an effective and safe option for managing dermatologic conditions in dogs, offering a targeted approach to enhance the quality of life for affected pets. Veterinary dermatologists are adopting precision medicine approaches to offer personalized treatment plans based on specific conditions. Increased availability of hypoallergenic diets and nutraceuticals is supporting holistic management of canine skin health issues. Innovations in diagnostic tools are enabling faster identification of dermatological diseases for effective treatment interventions. The expansion of veterinary telemedicine is improving access to dermatology consultations and remote treatment recommendations, thus strengthening market growth.

Animal Health Market Trends:

Increasing Focus on Preventive Healthcare

The animal health industry statistics suggest that it is experiencing a significant shift toward preventive healthcare practices for both companion animals and livestock. Pet parents and livestock producers recognize the importance of early detection and proactive management of health issues to improve overall animal well-being and reduce the risk of diseases. In May 2022, Government of India launched the Livestock Health and Disease Control Schemes with a ₹525 crore budget to manage critical livestock diseases and improve animal health nationwide. Additionally, efforts focus on making animal husbandry more cost-effective, as diseases cause 10-15% of production losses in livestock operations. Preventive healthcare practices are also on the rise among Gen Z pet parents across countries. For example, in India, there has been a significant rise in visits to the veterinarian, regulation of timely vaccinations, and eagerness for feeding pets with balanced and nutritious diets. As per the data published by the Global Health Security Index, Mexico, the Ministry of Health published its National Health Promotion Days plan, which includes the Guidelines for Disease Prevention and Control Programs: Zoonosis. The recommendations reflect on the idea of One Health and notably address campaigns to stop and prevent the spread of brucellosis, rabies, and porcine tapeworm.

Advancements In Biotechnology and Pharmaceuticals

The animal health industry is experiencing swift progress in biotechnology and pharmaceuticals, changing how diseases in animals are diagnosed and treated. Advanced research and groundbreaking technologies are driving the creation of specialized therapies, vaccines, and precision medicines designed for particular animal species and health conditions. Biotechnological advancements, including gene editing, cell therapies, polymerase chain reaction (PCR), DNA sequencing, and more, provide hopeful answers for difficult diseases. Furthermore, drug manufacturers are putting resources into research and development (R&D) to produce more efficient and safer drugs for animals. For example, QBiotics Group Limited (QBiotics), an Australian life sciences firm, is creating novel small-molecule anticancer and wound-healing medications. They have obtained approval from the Australian Pesticides and Veterinary Medicines Authority (APVMA) for their veterinary product STELFONTA (tigilanol tiglate). This endorsement marks Australia's initial pharmaceutical therapy accessible for all levels of canine non-metastatic medium chain triglycerides (MCT). Biotechnology is enabling the development of sophisticated imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT) scans, to offer comprehensive information regarding the internal structures and irregularities in animals, encompassing both pets and livestock.

Growing Pet Humanization and Specialty Pet Care

This relationship between humans and their pets continues to evolve toward pet humanization. Pets increasingly become part of the family circle, and in doing so create a significant transformation in customer behavior in the market of pet care. For instance, in the United States, 35% of young adults (24-35 years old) have either adopted a pet or intend to do so in the near future, and 19% have adopted a new pet during the COVID-19 lockdown. Pet parents are willing to spend more on premium and specialized pet care products and services to ensure their beloved companions lead healthy and fulfilling lives. This trend is increasing the demand for high-quality pet nutrition products, personalized treatments, advanced veterinary care, and a wide range of specialty items. For example, the requirement for pet care products, such as activity tracking collars, has increased recently, especially from the millennial or Gen Y generation, to measure the agility of their pet, to play sports with them, etc. In the United Kingdom, 100,000 dogs are currently fitted with activity monitoring devices, reports PitPat, a leading manufacturer of dog activity monitors.

Animal Health Market Segmentation:

Analysis by Animal Type:

  • Commercial
  • Companion

The commercial segment typically includes animals, such as livestock and poultry, that are reared for commercial needs like milk and meat. Producers and farmers are increasingly focused on maintaining the health and productivity of their herds or flocks due to the rising demand for animal-derived products, including meat, dairy, and eggs. Healthy animals lead to higher yields and improved product quality, which directly impacts the profitability of commercial operations. To achieve optimal productivity, producers are investing in preventive healthcare measures, like vaccinations, parasite control, and disease management. This in turn, is augmenting the demand for a wide range of animal health products, such as vaccines, pharmaceuticals, feed additives, and hygiene solutions. The rising collaboration between commercial animal producers and veterinary professionals ensures the implementation of best practices in animal health management, thus strengthening the market growth. For instance, the Asian Development Bank (ADB) invested $10 million in Zenex Animal Health India Private Limited (Zenex) for improving the overall production and distribution of better animal healthcare products, aiming to reduce livestock disease risks and improve farmer incomes.

Analysis by Product Type:

  • Pharmaceuticals
  • Biologicals
  • Medicinal Feed Additives
  • Diagnostics

In 2025, pharmaceuticals dominate the market with a 57.0% share. Pharmaceutical products address the needs of both pets and farm animals, assisting in disease prevention and treatment, managing chronic illnesses, and improving overall animal health. Veterinary pharmaceutical firms are significantly investing in research and development (R&D) to produce innovative and effective medications designed for particular animal species and health requirements, thus aiding in the growth of the segment. For example, in March 2022, Hacarus Inc., collaborating with DS Pharma Animal Health, introduced an ECG platform designed to assess and analyze heart conditions in dogs, facilitating early diagnosis of cardiac diseases, which are the second primary cause of death among canines. Additionally, ongoing progress in pharmaceutical technologies, like controlled-release formulations and tailored medicine, enhances treatment results even more. For example, the Canadian Food Inspection Agency oversees veterinary biologics like vaccines to guarantee that the products administered to animals in the nation are pure, potent, safe, and effective. To bring veterinary vaccines into the country, a valid import permit issued by the CFIA-CCVB in Ottawa is necessary.

Regional Analysis:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

In 2025, North America accounted for the largest market share of 44.9%. The region encompasses a huge pet parents' population that is focusing on the overall health and well-being of their companion animals, which is catalyzing the need for veterinary products and services. The continuously growing livestock industry in the region is also contributing to the requirement of animal health solutions for sustaining the productivity and health of the commercial animal sector. Moreover, a considerable number of pharmaceutical companies and research institutions are operating in the region that fosters continuous innovation in animal health products, including pharmaceuticals, diagnostics and vaccines, which, in turn, is propelling the market growth. Another major contributing factor is the support via government regulations and initiatives that is promoting animal welfare and biosecurity and encouraging investments in the animal health industry, thereby propelling the market growth. In April 2022, the FDA approved bovine somatotrophin, an animal growth hormone, to enhance milk production in dairy cows. Authorities are promoting industry participation and hormone therapies across the globe to strengthen North America's market growth.

Animal Health Market Regional Takeaways:

United States Animal Health Industry Analysis

The United States accounts for 86.50% of the animal health market share in North America. The United States market is influenced by various drivers, such as growing awareness of animal health, advances in veterinary medicine, and a rising demand for animal-derived products. A rising number of pet parents in the region increases the expenditure on pet care and veterinary services. In 2024, 66% of US households have adopted a pet, as stated in reports. In this regard, the increase in green and ethical productions of farming is prompting a growing demand for health solutions that ensure the well-being of livestock. This includes providing animals with better living conditions, reducing the use of antibiotics, and focusing on more natural farming processes. This is rising the demand for high-end animal health solutions that enhance the prevention of disease, animal welfare, and productivity while being ethical. Apart from this, innovations in pharmaceuticals, vaccines, and diagnostics, particularly chronic diseases and zoonotic infections, are fueling market growth. There is also an increased emphasis on food safety, where improved animal health would direct impact on the safety and quality of meat, dairy, and other animal-based products. Additionally, government regulations and initiatives, such as antimicrobial stewardship programs, do affect market dynamics as they require safer usage and encourage companies to develop better animal health solutions.

Asia Pacific Animal Health Industry Analysis

The market is growing rapidly in Asia Pacific, driven by the increasing consumption and production of meat, increasing awareness about animal diseases, and the rapid growth of the livestock sector in the region. Countries like China and India are experiencing high population growth, which is creating a larger demand for animal protein, such as poultry and beef, thereby driving the need for better animal healthcare. PIB reported the estimated total meat production in India during 2023-24 as 10.25 million tons, thereby increasing by a margin of 4.85% during the past decade. Apart from these trends, demand for veterinary services and pet products also grew, due to increasing urban-based pet parents. These include growing incidences of zoonotic diseases and the requirement for increased efficiency in disease control, which is propelling market growth as governments and health organizations are investing in more advanced diagnostics and treatments. Secondly, increased focus on food security and health in the global food supply chain in the region promotes greater investment in advancing animal health for risk-free high-quality food production. In addition, there is a movement towards sustainable and ethical farming practices that promotes farmers and producers to adopt the methods that benefit the welfare of livestock.

Europe Animal Health Industry Analysis

In Europe, the market is primarily influenced by the increasing demand for high-quality animal products, rising awareness among masses about animal welfare, and stricter regulatory standards. Moreover, the rising livestock population in the region is impelling the market growth. Reports indicate that in 2023, Spain held 25.4% of the EU's pig population and 23.6% of its sheep, while Greece accounted for 25.8% of the EU's goats, and France had 22.8% of the bovine population. In line with this, there is a rise in the trend of sustainable agriculture and livestock farming practices that prioritize animal well-being, resulting in higher spending on veterinary care, vaccines, and animal pharmaceuticals. Besides this, the European Union's commitment to food safety and biosecurity is inducing growth, as governments implement stricter regulations related to animal health and disease control. Additionally, the European market benefits from technological advancements in animal diagnostics and treatments, which contribute to improved livestock management. The rise of zoonotic diseases, such as avian influenza and African swine fever further highlights the importance of robust animal health solutions. The increasing focus on pet healthcare also play significant roles in driving demand for veterinary services in the region.

Latin America Animal Health Industry Analysis

The Latin American market is driven by the region's expanding livestock sector, particularly in countries like Brazil and Argentina, which are major exporters of meat and poultry. According to the Brazilian Animal Protein Association (ABPA), Brazil exported 5.138 million tons of poultry products in 2023. In addition, the increasing demand for protein-rich diets, along with the growing need for animal health products to ensure high-quality production, is bolstering the market growth. Besides this, increasing pet parents in urban areas is also contributing to the demand for veterinary care and related services. Governing agencies in the region are focusing on controlling animal diseases and improving agricultural productivity through improved animal health standards further supports the market's growth.

Middle East and Africa Animal Health Industry Analysis

The region's growing demand for livestock products, including dairy, meat, and eggs is offering a favorable market outlook. Rapid urbanization and the rising consumption of animal-based food items is contributing to the market's expansion. Additionally, the prevalence of zoonotic diseases and the need for effective animal disease control systems play a significant role in promoting investments in veterinary care and animal health solutions. The rising awareness of animal welfare and health issues among pet parents is strengthening the market growth. Apart from this, growing number of pet parents is bolstering the market growth in the region. Industry reports estimates that there were 928.4 Million pets in the UAE in 2023.

List of Top Animal Health Companies:

Pharmaceutical companies are developing advanced veterinary drugs, vaccines, and biologics to prevent and treat animal diseases effectively. Diagnostic firms are introducing rapid and accurate testing solutions to enhance disease detection and monitoring efforts. Biotechnology companies are leveraging genetic engineering and microbiome research to create targeted therapies and nutritional supplements. Veterinary service providers are expanding telemedicine and digital health platforms to improve accessibility and treatment outcomes. Government agencies are implementing stringent regulations and funding initiatives to ensure animal welfare and food safety compliance. Livestock producers are adopting precision farming technologies to enhance productivity, disease prevention, and overall animal well-being. Pet food manufacturers are formulating nutritionally enhanced diets with functional ingredients to support animal health. Research institutions are collaborating with industry leaders to develop novel therapeutic approaches and disease management strategies. For example, in February 2024, Merck Animal Health, a subsidiary of Merck has acquired Elanco Animal Health's aqua business outside the US and Canada for 1.3 billion USD. This acquisition includes a portfolio of medicines, vaccines, nutritional, and supplements for aquatic species, along with manufacturing facilities in Canada and Vietnam, and a research facility in Chile.

The report provides a comprehensive analysis of the top animal health companies in the market with detailed profiles of all major companies, including:

  • Bayer
  • Elanco
  • Merck
  • Merial
  • Zoetis Inc.
  • Biogenesis Bago
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Heska
  • Neogen
  • Novartis
  • Thermo Fisher Scientific
  • Vetoquinol
  • Virbac

Key Questions Answered in This Report

  • 1.How big is the animal health market?
  • 2.What is the future outlook of animal health market?
  • 3.What are the key factors driving the animal health market?
  • 4.Which region accounts for the largest animal health market share?
  • 5.Which are the leading companies in the global animal health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Animal Health Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Animal Type
  • 5.5 Market Breakup by Product Type
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Commercial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Companion
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Pharmaceuticals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biologicals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Medicinal Feed Additives
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Global Animal Health Industry: SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Global Animal Health Industry: Value Chain Analysis

11 Global Animal Health Industry: Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Global Animal Health Industry: Price Analysis

  • 12.1 Key Price Indicators
  • 12.2 Price Structure
  • 12.3 Margin Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Bayer
    • 13.3.2 Elanco
    • 13.3.3 Merck
    • 13.3.4 Merial
    • 13.3.5 Zoetis Inc.
    • 13.3.6 Biogenesis Bago
    • 13.3.7 Boehringer Ingelheim
    • 13.3.8 Ceva Sante Animale
    • 13.3.9 Heska
    • 13.3.10 Neogen
    • 13.3.11 Novartis
    • 13.3.12 Thermo Fisher Scientific
    • 13.3.13 Vetoquinol
    • 13.3.14 Virbac

List of Figures

  • Figure 1: Global: Animal Health Market: Major Drivers and Challenges
  • Figure 2: Global: Animal Health Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Animal Health Market: Breakup by Animal Type (in %), 2025
  • Figure 4: Global: Animal Health Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Animal Health Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Animal Health Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Animal Health Industry: SWOT Analysis
  • Figure 8: Global: Animal Health Industry: Value Chain Analysis
  • Figure 9: Global: Animal Health Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Animal Health (Commercial) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Animal Health (Commercial) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Animal Health (Companion) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Animal Health (Companion) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Animal Health (Pharmaceuticals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Animal Health (Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Animal Health (Biologicals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Animal Health (Biologicals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Animal Health (Medicinal Feed Additives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Animal Health (Medicinal Feed Additives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Animal Health (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Animal Health (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: North America: Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: North America: Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Europe: Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Europe: Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Asia Pacific: Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Asia Pacific: Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Middle East and Africa: Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Middle East and Africa: Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Latin America: Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Latin America: Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Animal Health Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Animal Health Market Forecast: Breakup by Animal Type (in Million USD), 2026-2034
  • Table 3: Global: Animal Health Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 4: Global: Animal Health Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Animal Health Market: Competitive Structure
  • Table 6: Global: Animal Health Market: Key Players